iStock-914788012-01.jpg

GOVERNANCE

Can-DESyNe will operate distinctly from Genome Canada by administration through a newly created SynBio Centre of Innovation and Entrepreneurship (CIE). The CIE, National Synthetic Biology Steering Committee, Genome Canada Enterprise and key Partners will define the governance necessary for transparent and fair decision-making for project selection and IP ownership.

National Synthetic Biology Steering Committee 

  • Dr. Bettina Hamelin, President and CEO, Ontario Genomics (Chair) - BIO

  • Andrew Casey, President and CEO, BIOTECanada - BIO

  • Dr. Doane Chilcoat, Leader, Applied Science and Technology at Corteva Agriscience - BIO

  • Dr. Krishna Mahadevan, Professor, University of Toronto - BIO

  • Dr. Vincent Martin, Director, Centre for Applied Synthetic Biology, Concordia University - BIO

  • Dr. Keith Pardee, Canada Research Chair in Synthetic Biology and Human Health, University of Toronto - BIO

  • Dr. Roman Szumski, VP Life Sciences, National Research Council - BIO

  • Dr. Steve Webb, Executive Director and Chief Executive Officer, Global Institute for Food Security - BIO

  • Dr. Peter Zandstra, Director, Michael Smith Laboratories, University of British Columbia - BIO

PARTNER WITH US

Benefits include leading or participating in
projects, accessing customers, technology partners &
academic experts, and leveraging your investment dollars.

MaRS Centre, West Tower 661 University Avenue, Suite 490, Toronto, ON M5G 1M1  |  416-977-9582

©2019 by CAN-DESyNe. Proudly created with Wix.com